Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-defining study of OPC-41061 for hepatic edema (ascites)
jRCT2080220392Phase 2
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tolvaptan in ascites, hepatic edema and Cirrhosis, sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
tolvaptan
03
Conditions
asciteshepatic edemaCirrhosis
Beyond the preview
Go deeper on jRCT2080220392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220392.